Product Images Dactinomycin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Dactinomycin NDC 71288-129 by Meitheal Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula of Dactinomycin - dac00 0002 01

Structural Formula of Dactinomycin - dac00 0002 01

Principal Display Panel – Dactinomycin for Injection, USP 500 mcg Vial Label - dac00 0002 02

Principal Display Panel – Dactinomycin for Injection, USP 500 mcg Vial Label - dac00 0002 02

This is a description of a medication called Dactinomycin (NDC71288-129-02) for injection, which contains 500mcg per vial. It is to be used for the preparation of intravenous solutions only and is a cytotoxic agent, meaning it is potentially harmful. It is manufactured by Meitheal Pharmaceuticals in Chicago, USA and is labeled for prescription use only.*

Principal Display Panel – Dactinomycin for Injection, USP 500 mcg Carton - dac00 0002 03

Principal Display Panel – Dactinomycin for Injection, USP 500 mcg Carton - dac00 0002 03

This is a medical label for Dactinomycin. The drug is supplied in single-dose vials and contains danger and caution warnings. It contains 500mg of Dactinomycin, an inactive ingredient froswiciny 20mg, and sterile water for injection to reconstitute the drug. The dosage information for USP injection is included in the packaging. The label instructs to store the drug at a temperature between 20°C to 25°C, protect it from light and humidity and discard unused portions.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.